VIVS 8-K 2026-07-17

VivoSim Labs, INC. (VIVS) 8-K dated 2026-07-17 — accession 0001193125-26-306849. This URL is the filing, not the VIVS hub.

VivoSim Labs, INC. (VIVS) is a biotechnology company listed on NASDAQ.

VivoSim Labs, INC. filed a 8-K on 2026-07-17. Accession 0001193125-26-306849.

Cached items: 1.01, 3.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.

Not investment advice. The VIVS SEC hub lists recent forms. The stock page is the research view.